Vident Investment Advisory’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,896
Closed -$216K 1214
2021
Q3
$216K Sell
5,896
-1,972
-25% -$77.6K 0.01% 1070
2021
Q2
$309K Hold
7,868
0.01% 932
2021
Q1
$222K Buy
7,868
+29
+0.4% +$925 0.01% 956
2020
Q4
$251K Sell
7,839
-34
-0.4% -$1.04K 0.01% 846
2020
Q3
$254K Sell
7,873
-1,970
-20% -$61.4K 0.01% 797
2020
Q2
$271K Sell
9,843
-2,624
-21% -$56.9K 0.01% 778
2020
Q1
$223K Sell
12,467
-2,273
-15% -$54.8K 0.01% 741
2019
Q4
$370K Buy
14,740
+4,323
+41% +$94.6K 0.02% 622
2019
Q3
$186K Buy
+10,417
New +$217K 0.02% 445

Other funds holding HCM

Vident Investment Advisory's HCM Position: Q4 2021 in Review

Vident Investment Advisory sold out of HUTCHMED (HCM) in Q4 2021, closing a stake of 5,896 shares — an estimated $216K sold.

Vident Investment Advisory first reported a position in HCM in Q3 2019 and held it in 9 quarters. The position peaked at $370K in Q4 2019. 148 funds tracked by Wall St. Rank hold HCM as of Q4 2021.

  • Vident Investment Advisory reported no remaining HUTCHMED position as of Q4 2021 after selling out during the quarter.
  • Vident Investment Advisory sold 5,896 HUTCHMED shares in Q4 2021, an estimated $216K.
  • Vident Investment Advisory first reported a position in HUTCHMED in Q3 2019 and held it in 9 quarters.
  • Vident Investment Advisory's HUTCHMED position peaked at $370K in Q4 2019.
  • 148 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2021.

Based on Vident Investment Advisory's 13F filing for Q4 2021, filed 14 Feb 2022.